Patents by Inventor Solomon Tadesse ZELEKE

Solomon Tadesse ZELEKE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds
    Patent number: 11970491
    Abstract: A novel class of inhibitors of protein kinates that are useful in the treatment of cell proliferative diseases and conditions, and especially those characterised by over-expression of CDK4, CDK6 and/or cyclin D, including certain cancers of lung, breast, brain, central nervous system, colorectal cancer and leukaemias.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: April 30, 2024
    Assignee: AUCENTRA THERAPEUTICS PTY LTD
    Inventors: Shudong Wang, Solomon Tadesse Zeleke, Mingfeng Yu
  • N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS
    Publication number: 20220267315
    Abstract: A novel class of inhibitors of protein kinates that are useful in the treatment of cell proliferative diseases and conditions, and especially those characterised by over-expression of CDK4, CDK6 and/or cyclin D, including certain cancers of lung, breast, brain, central nervous system, colorectal cancer and leukaemias.
    Type: Application
    Filed: August 31, 2021
    Publication date: August 25, 2022
    Inventors: Shudong Wang, Solomon Tadesse ZELEKE, Mingfeng YU
  • N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS
    Publication number: 20200283431
    Abstract: A novel class of inhibitors of protein kinases that are useful in the treatment of cell proliferative diseases and conditions, and especially those characterised by over-expression of CDK4, CDK6 and/or cyclin D, including certain cancers of lung, breast, brain central nervous system, colorectal cancer and leukaemias.
    Type: Application
    Filed: October 11, 2019
    Publication date: September 10, 2020
    Inventors: Shudong WANG, Solomon Tadesse ZELEKE, Mingfeng YU
  • N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds
    Patent number: 10479785
    Abstract: A novel class of inhibitors of protein kinases that are useful in the treatment of cell proliferative diseases and conditions, and especially those characterised by over-expression of CDK4, CDK6 and/or cyclin D, including certain cancers of lung, breast, brain, central nervous system, colorectal cancer and leukaemias.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: November 19, 2019
    Assignee: AUCENTRA THERAPEUTICS PTY LTD
    Inventors: Shudong Wang, Solomon Tadesse Zeleke, Mingfeng Yu
  • N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS
    Publication number: 20180222900
    Abstract: A novel class of inhibitors of protein kinases that are useful in the treatment of cell proliferative diseases and conditions, and especially those characterised by over-expression of CDK4, CDK6 and/or cyclin D, including certain cancers of lung, breast, brain, central nervous system, colorectal cancer and leukaemias.
    Type: Application
    Filed: August 4, 2016
    Publication date: August 9, 2018
    Inventors: Shudong WANG, Solomon Tadesse ZELEKE, Mingfeng YU
  • N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds
    Patent number: RE49850
    Abstract: A novel class of inhibitors of protein kinases that are useful in the treatment of cell proliferative diseases and conditions, and especially those characterised by over-expression of CDK4, CDK6 and/or cyclin D, including certain cancers of lung, breast, brain, central nervous system, colorectal cancer and leukaemias.
    Type: Grant
    Filed: February 2, 2022
    Date of Patent: February 27, 2024
    Assignee: AUCENTRA THERAPEUTICS PTY LTD
    Inventors: Shudong Wang, Solomon Tadesse Zeleke, Mingfeng Yu